11-08 :: August 2011
net income attributable to Cabot Corporation was $62 million ($0.95 per diluted common share) which includes a $0.09 per share charge principally for re- structuring costs. Adjusted EPS was $1.04 per share.
Cabot Corp. has launched “Lumira™ aerogel” as the new brand name for its insulated daylighting systems. Previously, Cabot’s aerogel products were called Nanogel®
in several different market sectors – from building and industrial coatings to energy pipelines and even insulated apparel. Cabot’s rebranding strategy will give the products separate identities and new names for each different market sector
icroscopy business group of Carl Zeiss has granted a sublicense for patents relating to
LED fluorescence excitation in microscopy to Prior Scientific Ltd., Cambridge, UK. These patents protect the use of light emitting diodes for the excitation of fluorescence radiation in light microscopes.
The property rights, which are valid in the USA and Canada, were acquired by Carl Zeiss in 2005. Carl Zeiss uses this technology in a number of products such as iLED-module, Axio Scope FL and Colibri.2 for a wide range of applications extending from routine to high-end microscopy. The users benefit from the optimum flexibility and maximum specimen protec- tion offered by the LEDs as light sources for fluore- scence excitation.
http://www.zeiss.de C aerogel, a name used for all its applications
VD Equipment Corporation (NASADQ: CVV) announced record revenue, income and back-
log. Revenue for the three and six months ended June 30, 2011 was $7,508,000 and $13,713,000 respectively, an increase of 122.1% and 93.1% over the $3,381,000 and $7,103,000 revenue achieved during the three and six months ended June 30, 2010. Income from operations for the three and six months ended June 30, 2011 was $1,202,000 and $2,079,000 as compared to income of $126,000 and $73,000 respectively for the three and six months ended June 30, 2010.
Net Income of $778,000 for the three months ended June 30, 2011 resulted in earnings of $0.15 per sha- re, basic and $0.14 per share diluted as compared with net income of $104,000 or $0.02 per share, ba- sic and diluted for the three months ended June 30, 2010. Net income of $1,466,000 for the six months ended June 30, 2011 resulted in earnings of $0.29 per share, basic and $0.28 per share diluted com- pared to a net loss of ($30,000) or ($0.00) per share basic and diluted for the six months ended June 30,
hina Medical Technologies, Inc. (NASDAQ: CMED), and Leica Biosystems, a division of
Leica Microsystems, have established a sales, re- search and development collaboration to co-develop and market automated FISH kits to be used on the Leica BOND system. CMED will sell the automated FISH kits in China and Leica will have an option to sell the automated FISH kits in the rest of the world.